Asplatin enhances drug efficacy by altering the cellular response.

about

Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.

P2860

Q46271057-52AE94D0-0CFD-4BD0-9E1C-4DCA602F97E5

P2860

Asplatin enhances drug efficacy by altering the cellular response.

Item

http://www.wikidata.org/entity/Q48786961

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Asplatin enhances drug efficacy by altering the cellular response.

@en

Asplatin enhances drug efficacy by altering the cellular response.

@nl

type

Item

label

Asplatin enhances drug efficacy by altering the cellular response.

@en

Asplatin enhances drug efficacy by altering the cellular response.

@nl

prefLabel

Asplatin enhances drug efficacy by altering the cellular response.

@en

Asplatin enhances drug efficacy by altering the cellular response.

@nl

P1476

Asplatin enhances drug efficacy by altering the cellular response.

@en

P2093

Hongdong Shi

http://www.w3.org/2001/XMLSchema#string

Hongxia Wang

http://www.w3.org/2001/XMLSchema#string

Jun Wang

http://www.w3.org/2001/XMLSchema#string

Qinqin Cheng

http://www.w3.org/2001/XMLSchema#string

Yangzhong Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Current status and future prospects for satraplatin, an oral platinum analogue

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy.

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Caspase-9.

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.

The resurgence of platinum-based cancer chemotherapy.

Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance.

The BCL-2 family reunion.

Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.

P304

672-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C6MT00066E

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27125788

http://www.w3.org/2001/XMLSchema#string

Asplatin enhances drug efficacy by altering the cellular response.

about

P2860

P2860

Asplatin enhances drug efficacy by altering the cellular response.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698